USA - engelsk - NLM (National Library of Medicine)

medical purchasing solutions, llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin and other antibacterial drugs, gentamicin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. gentamicin sulfate injection, usp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa , proteus species (indole-positive and indole-negative), escherichia coli , klebsiella-enterobacter-serratia species, citrobacter species, and staphylococcus species (coagulase-positive and coagulase-negative). clinical studies have

USA - engelsk - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - amikacin sulfate (unii: n6m33094fd) (amikacin - unii:84319sgc3c) - amikacin sulfate injection usp is indicated in the short-term treatment of serious infections due to susceptible strains of gram-negative bacteria, including pseudomonas species, escherichia  coli , species of indole-positive and indole-negative proteus , providencia species, klebsiella-enterobacter-serratia species, and acinetobacter (mima-herellea ) species. clinical studies have shown amikacin sulfate injection usp to be effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and post-operative infections (including post-vascular surgery). clinical studies have shown amikacin also to be effective in serious complicated and recurrent urinary tract infections due to these organisms. aminoglycosides, including amikacin sulfate injection usp are not indicated in uncomplicated initial episodes of urin

Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

saudi pharmaceutical industries (spi), saudi arabia - colistin - powder for use in drinking water - 2000000 iu/g

Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

the arab pesticides & veterinary drugs manufacturing (mobedco), jordan - colistin - powder for use in drinking water - 800000 iu/g

Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

the arab pesticides & veterinary drugs manufacturing (mobedco), jordan - colistin - powder for use in drinking water - 800000 iu/g

Saudi-Arabia - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

the arab pesticides & veterinary drugs manufacturing (mobedco), jordan - colistin - powder for use in drinking water - 800000 iu/g

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - colistin sulphate - oral solution - 12 gm/100 ml

USA - engelsk - NLM (National Library of Medicine)

solaris pharma corporation - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets, usp and other antibacterial drugs, neomycin sulfate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. neomycin sulfate tablets, usp are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g. preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section). neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. t

Irland - engelsk - HPRA (Health Products Regulatory Authority)

forest laboratories uk ltd - colistin sulfate - syrup - 250,000 units/ml

Irland - engelsk - HPRA (Health Products Regulatory Authority)

forest laboratories uk ltd - colistin sulfate - tablets - 1,500,000 international unit